| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.05 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.06 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.095 | 0.06 |